Total Payments
$8,776
2024 Payments
$887.84
Companies
21
Transactions
563
Medicare Patients
9,155
Medicare Billing
$509,520
Payment Breakdown by Category
Food & Beverage$8,695 (99.1%)
Education$80.58 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,695 | 557 | 99.1% |
| Education | $80.58 | 6 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,337 | 234 | $0 (2024) |
| PFIZER INC. | $1,338 | 97 | $0 (2024) |
| Abbott Laboratories | $772.39 | 24 | $0 (2023) |
| Amgen Inc. | $627.59 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $591.59 | 45 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $584.45 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $366.22 | 27 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $348.89 | 18 | $0 (2021) |
| iRhythm Technologies, Inc. | $197.70 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $175.43 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $887.84 | 45 | Novartis Pharmaceuticals Corporation ($404.50) |
| 2023 | $1,084 | 62 | Novartis Pharmaceuticals Corporation ($413.00) |
| 2022 | $1,104 | 57 | Novartis Pharmaceuticals Corporation ($302.86) |
| 2021 | $981.77 | 49 | Abbott Laboratories ($266.11) |
| 2020 | $742.62 | 47 | Novartis Pharmaceuticals Corporation ($306.37) |
| 2019 | $1,622 | 104 | Novartis Pharmaceuticals Corporation ($656.28) |
| 2018 | $1,222 | 100 | Novartis Pharmaceuticals Corporation ($487.56) |
| 2017 | $1,133 | 99 | Novartis Pharmaceuticals Corporation ($568.25) |
All Payment Transactions
563 individual payment records from CMS Open Payments — Page 3 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardiology | ||||||
| 10/09/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.93 | General |
| Category: Cardiovascular | ||||||
| 10/04/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/22/2023 | iRhythm Technologies, Inc. | ZIO XT Patch (Device) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/21/2023 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $50.93 | General |
| Category: Vascular | ||||||
| 09/20/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Cardiology | ||||||
| 09/18/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardiology | ||||||
| 09/13/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.40 | General |
| Category: Cardiovascular | ||||||
| 09/06/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/14/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Cardiology | ||||||
| 08/02/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: Cardiovascular | ||||||
| 07/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/28/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Cardiology | ||||||
| 06/21/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.54 | General |
| Category: Cardiovascular | ||||||
| 06/20/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $12.49 | General |
| Category: Cardiovascular | ||||||
| 06/16/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/14/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,100 | 2,771 | $302,695 | $110,147 |
| 2022 | 32 | 2,371 | 3,148 | $370,322 | $127,947 |
| 2021 | 32 | 2,499 | 3,207 | $405,840 | $144,137 |
| 2020 | 31 | 2,185 | 2,708 | $380,088 | $127,289 |
Total Patients
9,155
Total Services
11,834
Medicare Billing
$509,520
Procedure Codes
125
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 504 | 739 | $84,246 | $34,629 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 195 | 235 | $39,905 | $15,161 | 38.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 108 | $21,600 | $9,396 | 43.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 74 | 149 | $20,562 | $8,517 | 41.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 95 | 97 | $22,329 | $6,640 | 29.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 60 | 62 | $16,430 | $5,813 | 35.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 92 | 93 | $13,113 | $4,666 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $11,745 | $4,042 | 34.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 71 | 71 | $11,005 | $3,849 | 35.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 113 | 116 | $9,706 | $3,085 | 31.8% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Office | 2023 | 27 | 27 | $5,724 | $2,280 | 39.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 167 | 245 | $12,985 | $2,034 | 15.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 228 | 350 | $5,250 | $1,791 | 34.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 38 | 82 | $6,560 | $1,585 | 24.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 74 | 74 | $2,960 | $1,100 | 37.2% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 54 | 55 | $4,125 | $939.06 | 22.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 27 | $2,025 | $916.34 | 45.3% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 23 | 23 | $3,202 | $901.20 | 28.1% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 21 | 21 | $2,488 | $757.11 | 30.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 74 | 74 | $1,924 | $723.76 | 37.6% |
| 75571 | Ct scan of heart with evaluation of blood vessel calcium | Office | 2023 | 24 | 24 | $1,413 | $475.87 | 33.7% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 11 | 12 | $940.00 | $305.32 | 32.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 11 | 12 | $900.00 | $217.15 | 24.1% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 14 | 14 | $518.00 | $186.48 | 36.0% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 16 | 16 | $1,040 | $135.20 | 13.0% |
About Dr. Charles Clogston, M.D
Dr. Charles Clogston, M.D is a Cardiovascular Disease healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962449728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Clogston, M.D has received a total of $8,776 in payments from pharmaceutical and medical device companies, with $887.84 received in 2024. These payments were reported across 563 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($8,695).
As a Medicare-enrolled provider, Clogston has provided services to 9,155 Medicare beneficiaries, totaling 11,834 services with total Medicare billing of $509,520. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology
- Location Little Rock, AR
- Active Since 06/01/2006
- Last Updated 03/24/2014
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1962449728
Products in Payments
- ENTRESTO (Drug) $2,906
- ELIQUIS (Drug) $1,274
- Repatha (Biological) $627.59
- PRALUENT (Drug) $447.74
- LEQVIO (Drug) $430.93
- XARELTO (Drug) $366.22
- MITRACLIP (Device) $326.07
- VYNDAQEL (Drug) $294.57
- FARXIGA (Drug) $290.73
- MitraClip System (Device) $266.11
- CHANTIX (Drug) $226.14
- Mitra Clip system (Device) $155.70
- MULTAQ (Drug) $143.85
- ZIO Patch (Device) $136.77
- PRALUENT (Biological) $135.19
- CAMZYOS (Drug) $119.15
- NEXLETOL (Drug) $76.29
- ZIO XT Patch (Device) $47.31
- PRALUENT ALIROCUMAB INJECTION (Biological) $40.24
- BRILINTA (Drug) $38.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Little Rock
Ian Cawich, Md, MD
Cardiovascular Disease — Payments: $368,183
Cardiovascular Disease $368,183
Dr. Christian Assad-Kottner, Md, MD
Cardiovascular Disease — Payments: $263,227
Cardiovascular Disease $263,227
Muhammad Waqas, Md, MD
Cardiovascular Disease — Payments: $249,282
Cardiovascular Disease $249,282
Ernesto Ruiz-Rodriguez, M.d, M.D
Cardiovascular Disease — Payments: $160,407
Cardiovascular Disease $160,407
William Rollefson, Md, MD
Cardiovascular Disease — Payments: $157,519
Cardiovascular Disease $157,519
Andre Paixao, Md, MD
Cardiovascular Disease — Payments: $120,888
Cardiovascular Disease $120,888